Gene therapy for cardiac arrhythmias

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Cardiovascular diseases are the leading global cause of mortality.
• Cardiac arrhythmias significantly contribute to cardiovascular disease burden.
• Conventional treatments for arrhythmias have limitations.

Purpose of the Study:

• To review the rationale for gene therapy in treating cardiac arrhythmias.
• To discuss various gene therapy technologies, including gene silencing, replacement, suppression-and-replacement, and editing.
• To summarize vector and delivery methods, and highlight current challenges.

Main Methods:

• Review of existing literature on gene therapy for cardiac arrhythmias.
• Analysis of different gene therapy approaches and their pros and cons.
• Summary of vector modalities and delivery strategies.
• Presentation of gene therapy examples for atrial and ventricular arrhythmias.

Main Results:

• Gene therapy presents a potential one-time curative strategy for cardiac arrhythmias.
• Different gene therapy technologies (silencing, replacement, editing) offer distinct advantages and disadvantages.
• Various vector and delivery systems are employed in the field.
• Successful preclinical and clinical examples exist for both atrial and ventricular arrhythmias.

Conclusions:

• Gene therapy holds significant promise for treating cardiac arrhythmias.
• Overcoming current challenges in vector delivery and technology application is crucial.
• Further research and development are needed to fully realize the potential of gene therapy for cardiovascular diseases.